NEKTAR THERAPEUTICS — Director's Dealing 2015

Sep 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-09-15

Reporting Person: WANG SUSAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-15	Stock Option	$12.80	A	12500	Acquired	2023-09-14	Common Stock (12500)	Direct
2015-09-15	Restricted Stock Unit	$	A	15000	Acquired	2023-09-14	Common Stock (15000)	Direct

Footnotes

F1: This option was granted on September 15, 2015 and vests in equal monthly installments over the one-year period following the grant date.

F2: Each restricted stock unit represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F3: This restricted stock unit award vests in full one year following the grant date.